Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1 GlobeNewswire - Wed Mar 5, 6:05AM CST

IVVD : 0.9149 (-9.42%)
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine Zacks Investment Research - Tue Feb 25, 5:30AM CST

For Immediate ReleaseChicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

NDLS : 1.3200 (-6.71%)
IVVD : 0.9149 (-9.42%)
APPS : 2.81 (-4.59%)
FUBO : 3.01 (-5.35%)
VNET : 11.43 (-0.35%)
5 Stocks That More Than Doubled Halfway Through Q1
5 Stocks That More Than Doubled Halfway Through Q1 Zacks Investment Research - Mon Feb 24, 9:46AM CST

After a weak start to 2025, Wall Street regained momentum, driven by solid corporate earnings and advancements in AI. The S&P 500 touched record highs on several occasions, having risen 2.2%, while the...

NDLS : 1.3200 (-6.71%)
IVVD : 0.9149 (-9.42%)
APPS : 2.81 (-4.59%)
FUBO : 3.01 (-5.35%)
VNET : 11.43 (-0.35%)
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the... GlobeNewswire - Mon Feb 24, 6:05AM CST

IVVD : 0.9149 (-9.42%)
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week Stocktwits - Mon Feb 10, 6:16AM CST

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.

MBX : 8.98 (-9.20%)
GHRS : 11.20 (+6.67%)
IVVD : 0.9149 (-9.42%)
RANI : 1.4800 (-5.13%)
LIPO : 2.18 (-4.59%)
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 GlobeNewswire - Mon Feb 10, 6:00AM CST

IVVD : 0.9149 (-9.42%)
Bullish - green stock market chart with arrow up day trade by Quality Stock Arts via Shutterstock
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here. Barchart - Thu Feb 6, 3:50PM CST

Investors could consider this penny stock after its COVID-19 antibody breakthrough sent shares soaring, and analysts see massive triple-digit gains ahead.

-MEBI : -31.39 (-0.74%)
IVVD : 0.9149 (-9.42%)
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold GlobeNewswire - Wed Feb 5, 8:30AM CST

IVVD : 0.9149 (-9.42%)
Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population GlobeNewswire - Mon Feb 3, 6:00AM CST

IVVD : 0.9149 (-9.42%)
Invivyd Announces Preliminary Fourth Quarter 2024 Financial Results, Strong Revenue Growth, and Reiterates Goal of Near-Term Profitability GlobeNewswire - Mon Feb 3, 5:55AM CST

IVVD : 0.9149 (-9.42%)

Barchart Exclusives

This Super Micro Computer Rival Just Hiked Its Dividend 18%. Is It a Buy Now? Barchart - Mon Mar 10, 6:30PM CDT
Dell Technologies, a strong rival to Super Micro Computer, has increased its dividend by 18%, showcasing its financial stability and growth potential, and prompting investors to consider whether now is a good time to buy into its promising tech story. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot